Sheffield Institute for
Translational Neuroscience

Contact:

SITraN Communications
Rebecca Brown
E: rebecca.brown@sheffield.ac.uk
T: +44 (0)114 222 2261

Latest News

29.07.2021

Innovative gene therapy programme paves the way for new treatments for neurodegenerative diseases

An innovative gene therapy programme which could pave the way for novel treatments for neurodegenerative diseases, has been launched at the University of Sheffield in collaboration with the Cell and Gene Therapy Catapult. 

Read more

11.06.2021

Frequent strenuous exercise increases the chance of developing MND in genetically at risk individuals

Scientists at the University of Sheffield believe the pioneering study represents a significant step towards unravelling the link between high levels of physical activity and the development of the neurodegenerative condition which affects approximately 5,000 people in the UK.

Read more

18.03.2021

​​​​​​​New gene therapy innovation centre to advance scientific discoveries into life-changing treatments

A pioneering gene therapy innovation centre at the University of Sheffield is set to advance scientific discoveries into promising treatment options for millions of patients with life-threatening diseases. 

Read more

09.03.2021

Sheffield scientists awarded £1.2 million to design Parkinson’s drug

Scientists from the University of Sheffield have been awarded £1.2 million to develop a drug to protect dopamine-producing brain cells and slow down the progression of Parkinson’s Disease.

Read more

15.02.2021

New study suggests genetic testing could be appropriate for all motor neuron disease (MND) patients whether or not they have a family history of the disease

Research from the Sheffield Institute for Translational Neuroscience (SITraN) suggests that routine genetic testing may be appropriate for all MND patients and could impact disease subclassification and clinical care.

Read more

RSS Icon

New SITraN blog

Find out more about our work

SITraN seminar series